Related Experiment Videos
Genetics of neonatal hyperinsulinism
B Glaser1, P Thornton, T Otonkoski
1Department of Endocrinology and Metabolism, The Hebrew University, Hadassah Medical School, Jerusalem, 91120, Israel. beng@cc.huji.ac.il
Archives of Disease in Childhood. Fetal and Neonatal Edition
|February 24, 2000
Summary
Congenital hyperinsulinism (HI) is a genetic disorder with varied severity. Genetic studies are clarifying its causes and improving patient management strategies.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Congenital hyperinsulinism (HI) presents with significant clinical and genetic heterogeneity.
- Severity ranges from life-threatening to mild, impacting diagnosis and management.
- Variability in response to medical and surgical treatments is a key challenge.
Purpose of the Study:
- To elucidate the molecular etiology of congenital hyperinsulinism.
- To understand the genetic basis of clinical heterogeneity in HI.
- To explore the role of genetic findings in patient management.
Main Methods:
- Identification of mutations in genes associated with beta cell function.
- Analysis of genetic causes including K(ATP) channel subunits, glucokinase, and glutamate dehydrogenase.
- Investigating undetermined genetic etiologies in a significant portion of cases.
Main Results:
- Mutations in four distinct genes have been identified in HI patients.
- K(ATP) channel subunit mutations account for most identified genetic causes.
- Genetic mutations in glucokinase and glutamate dehydrogenase are also implicated.
- Approximately 50% of HI cases lack a determined genetic cause.
Conclusions:
- Genetic studies are advancing our understanding of beta cell physiology.
- While clinical applications are evolving, genetic analysis can aid in managing congenital hyperinsulinism.
- Further research is needed to identify the genetic basis for remaining HI cases.